129 related articles for article (PubMed ID: 7809019)
1. Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats.
Tomita H; Miyasaka K; Jimi A; Mishima Y; Funakoshi A
Pancreas; 1994 Sep; 9(5):638-45. PubMed ID: 7809019
[TBL] [Abstract][Full Text] [Related]
2. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
4. The effect of the CCK receptor antagonist CR 1409 on bile reflux pancreatitis in the opossum.
Larsen F; Schlarman D; Andrus CC; Kaminski DL
Pancreas; 1991 May; 6(3):291-7. PubMed ID: 1713673
[TBL] [Abstract][Full Text] [Related]
5. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression of pancreatitis-associated protein and pancreatic secretory trypsin inhibitors in experimental pancreatitis produced by pancreatic duct occlusion in rats: comparison with gene expression of cholecystokinin and secretin.
Funakoshi A; Miyasaka K; Jimi A; Nakamura E; Teraoka H
Pancreas; 1995 Aug; 11(2):147-53. PubMed ID: 7479671
[TBL] [Abstract][Full Text] [Related]
7. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.
Miyasaka K; Ohta M; Tateishi K; Jimi A; Funakoshi A
Pancreas; 1998 Mar; 16(2):114-23. PubMed ID: 9510132
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T
Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.
Miyasaka K; Funakoshi A; Jimi A; Nakamura R; Matsumoto M; Kitani K
Dig Dis Sci; 1992 Mar; 37(3):369-77. PubMed ID: 1735360
[TBL] [Abstract][Full Text] [Related]
10. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.
Niederau C; Borchard F; Lüthen R; Niederau M
Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946
[TBL] [Abstract][Full Text] [Related]
11. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
Otsuki M; Nakano S; Tachibana I
Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
[TBL] [Abstract][Full Text] [Related]
12. Effects of cholecystokinin receptor antagonist loxiglumide on rat exocrine pancreas.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1994 Jul; 9(4):425-33. PubMed ID: 7937691
[TBL] [Abstract][Full Text] [Related]
13. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.
Imoto I; Yamamoto M; Jia DM; Otsuki M
Int J Pancreatol; 1997 Dec; 22(3):177-85. PubMed ID: 9444548
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endogenous cholecystokinin in the development of acute pancreatitis induced by closed duodenal loop.
Tani S; Itoh H; Koide M; Okabayashi Y; Otsuki M
Pancreas; 1993 Jan; 8(1):109-15. PubMed ID: 7678322
[TBL] [Abstract][Full Text] [Related]
16. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats.
Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H
Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983
[TBL] [Abstract][Full Text] [Related]
18. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Jia D; Yamamoto M; Otsuki M
World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
[TBL] [Abstract][Full Text] [Related]
19. [Effects of CR1505, a CCK antagonist, on pancreatic growth in hamsters].
Tasi Y; Baba N; Nishimura I; Manabe T; Tobe T
Nihon Shokakibyo Gakkai Zasshi; 1991 Apr; 88(4):1097-104. PubMed ID: 1857003
[TBL] [Abstract][Full Text] [Related]
20. Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA.
Sazaki N; Miyasaka K; Matsumoto M; Funakoshi A
J Gastroenterol; 1995 Oct; 30(5):599-606. PubMed ID: 8574331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]